Cell Surface Markers Market Research Report โ€“ Global Forecast till 2030

Cell Surface Markers Market Size, Trends and Industry Outlook by Product (Antibody, PCR Array), by Source (Mice, Rat), by Cell Type (T Cells, B Cells, NK Cells), by Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)) - Global Forecast Till 2030

ID: MRFR/HC/5941-HCR | August, 2022 | Region : Global

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Product Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porterโ€™s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Cell Surface Markers Market, by Product

6.1 Introduction

6.2 Antibody

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 PCR Array

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Cell Surface Markers Market, by Source

7.1 Introduction

7.2 Mice

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Rat

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Cell Surface Markers Market, by Cell Type

8.1 Introduction

8.2 T Cells

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 B Cells

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 NK Cells

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Cell Surface Markers Market, by Applications

9.1 Introduction

9.2 Research

9.2.1 Stem Cell

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.2.2 Immunology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Clinical

9.3.1 Oncology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3.2 Hematology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Cell Surface Markers Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Bio-Rad Laboratories, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Siemens Healthcare Private Limited

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Beckman Coulter, Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 NIHON KOHDEN CORPORATION

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 F. Hoffman-La Roche Ltd.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 BD

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Abcam plc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 QIAGEN

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Thermo Fisher Scientific

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Abbott

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Danaher

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 GenScript

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Merk KGaA

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 BioLegend, Inc.

12.14.1 Overview

12.14.2 Product Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Cell Signaling Technology, Inc.

12.15.1 Overview

12.15.2 Product Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

12.16 Bio-Techne

12.16.1 Overview

12.16.2 Product Overview

12.16.3 Financials

12.16.4 Key Developments

12.16.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEOโ€™s View point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Cell Surface Markers Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Cell Surface Markers Market Synopsis, 2020-2027

Table 2 Global Cell Surface Markers Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Cell Surface Markers Market, by Region, 2020-2027 (USD Million)

Table 4 Global Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 5 Global Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 6 Global Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 7 Global Cell Surface Markers Market, by Applications, 2020-2027 (USD Million)

Table 8 North America: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 10 North America: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 11 North America: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 12 US: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 13 US: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 14 US: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 15 US: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 16 Canada: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 17 Canada: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 18 Canada: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 19 Canada: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 20 South America: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 21 South America: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 22 South America: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 23 South America: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 24 Europe: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 25 Europe: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 26 Europe: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 27 Europe: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 28 Western Europe: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 29 Western Europe: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 30 Western Europe: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 31 Western Europe: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 32 Eastern Europe: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 33 Eastern Europe: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 34 Eastern Europe: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 35 Eastern Europe: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 38 Asia-Pacific: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 39 Asia-Pacific: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Cell Surface Markers Market, by Product, 2020-2027 (USD Million)

Table 41 Middle East & Africa: Cell Surface Markers Market, by Source, 2020-2027 (USD Million)

Table 42 Middle East & Africa: Cell Surface Markers Market, by Cell Type, 2020-2027 (USD Million)

Table 43 Middle East & Africa: Cell Surface Markers Market, by Application, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Cell Surface Markers Market

Figure 3 Market Dynamics for Global Cell Surface Markers Market

Figure 4 Global Cell Surface Markers Market Share, by Product, 2020

Figure 5 Global Cell Surface Markers Market Share, by Source, 2020

Figure 6 Global Cell Surface Markers Market Share, by Cell Type, 2020

Figure 7 Global Cell Surface Markers Market Share, by Application, 2020

Figure 8 Global Cell Surface Markers Market Share, by Region, 2020

Figure 9 North America: Cell Surface Markers Market Share, by Country, 2020

Figure 10 Europe: Cell Surface Markers Market Share, by Country, 2020

Figure 11 Asia-Pacific: Cell Surface Markers Market Share, by Country, 2020

Figure 12 Middle East & Africa: Cell Surface Markers Market Share, by Country, 2020

Figure 13 Global Cell Surface Markers Market: Company Share Analysis, 2020 (%)

Figure 14 Bio-Rad Laboratories, Inc.: Key Financials

Figure 15 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 16 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 17 Siemens Healthcare Private Limited: Key Financials

Figure 18 Siemens Healthcare Private Limited: Segmental Revenue

Figure 19 Siemens Healthcare Private Limited: Geographical Revenue

Figure 20 Beckman Coulter, Inc.: Key Financials

Figure 21 Beckman Coulter, Inc.: Segmental Revenue

Figure 22 Beckman Coulter, Inc.: Geographical Revenue

Figure 23 NIHON KOHDEN CORPORATION: Key Financials

Figure 24 NIHON KOHDEN CORPORATION: Segmental Revenue

Figure 25 NIHON KOHDEN CORPORATION: Geographical Revenue

Figure 26 F. Hoffman-La Roche Ltd.: Key Financials

Figure 27 F. Hoffman-La Roche Ltd.: Segmental Revenue

Figure 28 F. Hoffman-La Roche Ltd.: Geographical Revenue

Figure 29 BD: Key Financials

Figure 30 BD: Segmental Revenue

Figure 31 BD: Geographical Revenue

Figure 32 Abcam plc: Key Financials

Figure 33 Abcam plc: Segmental Revenue

Figure 34 Abcam plc: Geographical Revenue

Figure 35 QIAGEN: Financials

Figure 36 QIAGEN: Segmental Revenue

Figure 37 QIAGEN: Geographical Revenue

Figure 38 Thermo Fisher Scientific: Key Financials

Figure 39 Thermo Fisher Scientific: Segmental Revenue

Figure 40 Thermo Fisher Scientific: Geographical Revenue

Figure 41 Abbott: Key Financials

Figure 42 Abbott: Segmental Revenue

Figure 43 Abbott: Geographical Revenue

Figure 44 Danaher: Key Financials

Figure 45 Danaher: Segmental Revenue

Figure 46 Danaher: Geographical Revenue

Figure 47 GenScript: Key Financials

Figure 48 GenScript: Segmental Revenue

Figure 49 GenScript: Geographical Revenue

Figure 50 Merk KGaA: Key Financials

Figure 51 Merk KGaA: Segmental Revenue

Figure 52 Merk KGaA: Geographical Revenue

Figure 53 BioLegend, Inc.: Key Financials

Figure 54 BioLegend, Inc.: Segmental Revenue

Figure 55 BioLegend, Inc.: Geographical Revenue

Figure 56 Cell Signaling Technology, Inc.: Key Financials

Figure 57 Cell Signaling Technology, Inc.: Segmental Revenue

Figure 58 Cell Signaling Technology, Inc.: Geographical Revenue

Figure 59 Bio-Techne: Key Financials

Figure 60 Bio-Techne: Segmental Revenue

Figure 61 Bio-Techne: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Cell Surface Markers Market

Cell Surface Markers Market size is expected to register a CAGR of 8.80 % and was valued at USD 1,415.05 Million.

Segmentation

By Product Antibody Pcr Array
By Source Mice Rat
By Cell Type T Cells B Cells Nk Cells
By Application Research Clinical

Key Players

  • Bio-Rad Laboratories
  • Inc.
  • Abbott
  • Siemens Healthcare Private Limited
  • Beckman Coulter
  • Inc.
  • F. Hoffmann-La Roche Ltd
  • NIHON KOHDEN CORPORATION
  • Thermo Fisher Scientific
  • BD
  • Abcam plc.
  • QIAGEN
  • Danaher
  • GenScript
  • Merk KGaA
  • BioLegend
  • Inc.
  • Cell Signaling Technology
  • Inc.
  • Bio-Techne and Others.

Drivers

  • Ris
  • ing inclination towards minimizing healthcare expenditure
  • Advancement in healthcare technology
Speak to Analyst Request a Free Sample